Cellectricon Launches Cellaxess® ACE – Adherent Cell Electroporation System
Mölndal, Sweden, Oct. 31, 2012
Cellectricon is pleased to announce the new Cellaxess ACE Adherent Cell Electroporation System which represents a revolutionary in-situ transfection of any adherent cell type.
Developed to meet the growing need for in-situ transfection of hard-to-transfect adherent cell types, the platform enables transfection and delivery of non-genetic material in any adherent cell type at any developmental stage.
The platform enables in-situ primary and iPSC-derived cell types directly in 96- and 384-well microplates and cell culture dishes at any cellular developmental stage with excellent viability and completely retained cellular morphology.
Cellaxess ACE is available as a complete system, but can also be integrated with third party pulse generators.
“We are thrilled with the Cellaxess system; it has allowed us to routinely transfect many different types of cultured primary neurons in their adherent state, something that has not previously been possible.” Professor Peter Baas, Department of Neurobiology and Anatomy, Drexel University, Philadelphia, USA
Applications for the Cellaxess ACE include transfection of various types of neuronal cells such as hippocampal and cortical neurons, dorsal root and superior cervical ganglia from rat as well as mouse, and human iPSC-derived dopaminergic neurons, to mention a few. Protocols are available for a wide range of neuronal cells as well as other adherent cell types.
Cellectricon is a leading provider of advanced cell-based screening technologies and services to accelerate drug discovery and cell-based assay research. Our proprietary technologies include leading systems for high resolution ion-channel screening and cell engineering. Developed in close collaboration with leaders in the pharmaceutical industry and esteemed research labs, the Cellaxess® Technology enables scalable field stimulation, compound delivery and transfection for genomic screening of primary cells, neurones and stem cells. The Dynaflow® Technology advances ion channel research and discovery applications. For more information about Cellectricon please visit www.cellectricon.com.
Johan Pihl, Cellaxess Product Manager
Phone: +46 (0)31 760 35 00